Skip to search boxSkip to navigationSkip to main content

Influence of tissue freezing on the binding of 125I-sarcosine1, isoleucine8 angiotensin II to angiotensin II receptor subtypes in the rat

  • ,
  • W. Zhang
    ,
  • K. L. Grove
    ,
  • R. C. Speth(corresponding author)
*Corresponding author for this work
  • Pharmacology
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Evaluation of angiotensin II (AII) receptor binding often necessitates freezing of the tissue of interest prior to assay of radioligand binding. This study evaluated the effects of freezing of various rat tissues at different rates on <sup>125</sup>I-sarcosine<sup>1</sup>, isoleucine<sup>8</sup> angiotensin II (<sup>125</sup>I-SI AII) binding to AII receptor subtypes. Slow freezing in a -20°C compartment significantly reduced <sup>125</sup>I-SI AII binding to AT<sub>1</sub> receptors in the adrenal (51%), epididymis (34%), and liver (22%). Binding of <sup>125</sup>I-SI AII to the AT<sub>1</sub> receptor in the brain was not significantly reduced. In the adrenal, both the Bmax and affinity of AT<sub>1</sub> receptors were decreased by freezing. But in the epididymis, only the affinity of AT<sub>1</sub> receptors was decreased. Binding of <sup>125</sup>I-SI AII to AT<sub>2</sub> receptors in the adrenal, epididymis, and brain was also not significantly reduced by freezing. Further evaluation of the mechanism of the reduction in <sup>125</sup>I-SI AII binding to AT<sub>1</sub> receptors in the adrenal indicated that both the receptor density and affinity for <sup>125</sup>I-SI AII were decreased by freezing. Rapid freezing in a dry-ice bath caused even greater reductions in <sup>125</sup>I-SI AII binding to AT<sub>1</sub> receptors in the adrenal. Snap freezing in liquid nitrogen decreased <sup>125</sup>I-SI AII binding in adrenals to a similar extent as did slow freezing. These results suggest that studies of AII receptor subtypes that involve freezing of the tissues underestimate the density and affinity of the AT<sub>1</sub> receptor subtype.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 83-90 (8 pages)

Journal (Volume, Issue Number)

Journal of Pharmacological and Toxicological Methods (Volume 33, Issue 2)

Publication milestones

  • Published - 04/1995

Publication status

Published - 04/1995

ISSN

1056-8719

Publication IDs

  • Scopus: 0028953958
  • PubMed: 7766920

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
4
Captures
6

Funding Details

Supported by USPHS Grant NS 21305, the Peptide Radioiodination Service Center, Washington State University, and a fellowship from the Poncin Medical Research Foundation, Seattle, WA, U.S.A. (K.L.G.). Losartan was generously provided by Dr. Ron Smith of the DuPont Merck Pharmaceutical Corp. PD 123177 was generously provided by Carol Gennain at Parke-Davis Pharmaceutical Research. I
FundersFunding number
Peptide Radioiodination Service Center
-
Poncin Medical Research Foundation
-
NINDS
R01NS021305
USPHS
-
WSU
-